Scientists advise that decisions about whether to introduce mitochondrial transplantation into treatment should be at the discretion of the Human Fertilisation and Embryology Authority

Scientists argue that decisions on the use of mitochondrial transtplantaion in clinical practice should be dealt with in the same manner as other new clinical treatments involving embryos and gametes. It should be at the discretion of the HFEA to grant a licence for such treatments.

See here for more details NESCI Brief on 2008 HFE Bill – Mitochondrial Transplants